Identification of lactate dehydrogenase A inhibitors using fragment-based lead generation

被引：0
|
作者：
Ward, Richard A.
Winter, Jon
De Savi, Chris
Greenwood, Ryan
Pearson, Stuart
Hooper, Alice
Tam, Kin
Hunter, Alison
Lane, Clare
Tucker, Julie
Brassington, Clare
Caputo, Alessandro
Vogtherr, Martin
Watson, Martin
Holdgate, Geoff
Davies, Gareth
Tart, Jonathan
Wingfield, Jonathan
Goodwin, Louise
Whalley, Nicky
Critchlow, Susan
Hudson, Kevin
机构：
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2011年 / 242卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
230-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Discovery of a novel warhead against β-secretase through fragment-based lead generation
    Geschwindner, Stefan
    Olsson, Lise-Lotte
    Albert, Jeffrey S.
    Deinum, Johanna
    Edwards, Philip D.
    de Beer, Tonny
    Folmer, Rutger H. A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (24) : 5903 - 5911
  • [42] MEDI 558-A success story of fragment-based lead generation at Astrazeneca
    Spadola, Loredana
    Hohwy, Morten
    Edman, Karl
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [43] From fragment-based lead generation to 2-aminoquinolines as potent beta-secretase inhibitors that are efficacious in vivo
    Cheng, Yuan
    Ashton, Kate
    Bartberger, Mike
    Brown, Jim
    Bryan, Callie
    Chen, Kui
    Esmay, Joel
    Fremeau, Robert T., Jr.
    Golden, Jennifer
    Harried, Scott
    Hickman, Dean
    Hitchcock, Stephen A.
    Huang, Ming
    Jordan, Brad
    Judd, Ted
    Lopez, Patricia
    Louie, Steven W.
    Luo, Yi
    Mercede, Stephanie
    Michelsen, Klaus
    Nixey, Thomas
    Paras, Nick A.
    Poon, Steve
    Powers, Timothy S.
    Sickmier, Allen
    Jean, David St
    Tegley, Chris
    Zhong, Wenge
    Wen, Paul
    Wahl, Robert C.
    Wood, Stephen
    Xue, May
    Yang, Bryant
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [44] Fragment-based lead discovery grows up
    Monya Baker
    Nature Reviews Drug Discovery, 2013, 12 : 5 - 7
  • [45] Discovery of Selective 4-Amino-pyridopyrimidine Inhibitors of MAP4K4 Using Fragment-Based Lead Identification and Optimization
    Crawford, Terry D.
    Ndubaku, Chudi O.
    Chen, Huifen
    Boggs, Jason W.
    Bravo, Brandon J.
    DeLaTorre, Kelly
    Giannetti, Anthony M.
    Gould, Stephen E.
    Harris, Seth F.
    Magnuson, Steven R.
    McNamara, Erin
    Murray, Lesley J.
    Nonomiya, Jim
    Sambrone, Amy
    Schmidt, Stephen
    Smyczek, Tanya
    Stanley, Mark
    Vitorino, Philip
    Wang, Lan
    West, Kristina
    Wu, Ping
    Ye, Weilan
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (08) : 3484 - 3493
  • [46] Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening
    Szaszko, Maria
    Hajdu, Istvan
    Flachner, Beata
    Dobi, Krisztina
    Magyar, Csaba
    Simon, Istvan
    Lorincz, Zsolt
    Kapui, Zoltan
    Pazmany, Tamas
    Cseh, Sandor
    Dorman, Gyorgy
    MOLECULAR DIVERSITY, 2017, 21 (01) : 175 - 186
  • [47] Identification of DNA primase inhibitors via a combined fragment-based and virtual screening
    Ilic, Stefan
    Akabayov, Sabine R.
    Arthanari, Haribabu
    Wagner, Gerhard
    Richardson, Charles C.
    Akabayov, Barak
    SCIENTIFIC REPORTS, 2016, 6
  • [48] Identification of DNA primase inhibitors via a combined fragment-based and virtual screening
    Stefan Ilic
    Sabine R. Akabayov
    Haribabu Arthanari
    Gerhard Wagner
    Charles C. Richardson
    Barak Akabayov
    Scientific Reports, 6
  • [49] A rule of three for fragment-based lead discovery?
    Congreve, M
    Carr, R
    Murray, C
    Jhoti, H
    DRUG DISCOVERY TODAY, 2003, 8 (19) : 876 - 877
  • [50] Fragment-based lead discovery: leads by design
    Carr, RAE
    Congreve, M
    Murray, CW
    Rees, DC
    DRUG DISCOVERY TODAY, 2005, 10 (14) : 987 - 992
12345